PRAMEF15: A Potential Drug Target and Biomarker for PRAME Family Members

Target Name: PRAMEF15

NCBI ID: G653619

PRAMEF15

Other Name(s): PRAME family member 15 | PRAME family member 9 | PRAME family member 9/15

PRAMEF15: A Potential Drug Target and Biomarker for PRAME Family Members

PRAMEF15, also known as PRAMEF15, is a protein that belongs to the PRAME family, which is a group of proteins known for their role in cell signaling and inflammation. PRAMEF15 has been identified as a potential drug target and biomarker for the treatment of various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

The PRAME family of proteins is characterized by the presence of a farnesylated cysteine residue, which is important for the stability and functions of the proteins. PRAMEF15 is no exception to this rule, as it also has a farnesylated cysteine residue. The unique feature of PRAMEF15 is its structure, as it has a distinct N-terminal region that is different from other PRAME family members.

PRAMEF15 has been shown to play a crucial role in various physiological processes in the body, including cell signaling, inflammation, and stress response. It is a key regulator of the NF-kappa-B signaling pathway, which is involved in the regulation of inflammation, cell survival, and metabolism. PRAMEF15 has also been shown to play a role in the development and progression of various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

As a potential drug target, PRAMEF15 is of particular interest to researchers because of its involvement in the regulation of cell signaling and inflammation. Many diseases, including cancer and autoimmune disorders, are characterized by chronic inflammation that is difficult to control. PRAMEF15 may be a useful target for the development of new treatments for these diseases because it is thought to be involved in the regulation of the immune response and the inflammatory response.

In addition to its potential as a drug target, PRAMEF15 may also be a useful biomarker for the diagnosis and monitoring of various diseases. The PRAME family of proteins has been shown to be involved in the regulation of a wide range of cellular processes, including cell signaling, inflammation, and stress response. By studying the levels and activity of PRAMEF15, researchers may be able to develop new diagnostic tests for various diseases and monitor the effectiveness of new treatments.

Overall, PRAMEF15 is a protein that has the potential to be a drug target and biomarker for the treatment of a wide range of diseases. Further research is needed to fully understand its role in the regulation of cell signaling and inflammation, and to develop new treatments based on its properties.

Protein Name: PRAME Family Member 15

The "PRAMEF15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRAMEF15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets